Kukje to develop a new oral Carbapenem antibiotic

Published: 2005-07-15 06:56:00

Updated: 2005-07-15 06:56:00

Kukje pharmaceutical company announced that they jointly discovered two carbapenem antibiotics, KR-34008 and KR-34020 with Korea Institute of Chemical Technology (KRICT) and put them into the preclinical studies, which showed an excellent sensitivity against the resistant PBP bacteria.

Kukje s...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK